News
Biocon Biologics Secures Japan Approval for Pegfilgrastim Biosimilar
The approval of pegfilgrastim biosimilar further strengthens Biocon’s portfolio of biosimilar products in Japan.
E-MAIL: your-email@mail.com
E-MAIL: your-email@mail.com
The approval of pegfilgrastim biosimilar further strengthens Biocon’s portfolio of biosimilar products in Japan.
HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 9354115542
HealthXploreIndia @2026. All Rights Reserved.
